Succinate dehydrogenase inhibitors (SDHi's)
US10603298B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Inventors
Key dates
| Filing date | Jul 3, 2015 |
| Grant date | Mar 31, 2020 |
| Priority date | — |
| Expiry date | Jul 3, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a succinate dehydrogenase inhibitor or a prodrug and/or a pharmaceutically acceptable salt thereof for use in the treatment or prevention of reperfusion injury, such as ischemia-reperfusion injury, by inhibiting the accumulation of succinate, wherein the inhibitor or prodrug and/or pharmaceutically acceptable salt thereof is a cell-permeable reversible inhibitor of succinate dehydrogenase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.